T cells expressing a chimeric antigen receptor

Marcela Maus; Maria Ormhøj; Torben Barington

T cells expressing a chimeric antigen receptor

Marcela Maus (Opfinder), Maria Ormhøj (Opfinder), Torben Barington (Opfinder)

Massachusetts General Hospital

Publikation: Patent

Abstrakt

Described herein are methods for producing and utilizing T cells comprising chimeric antigen receptors (CAR) comprising an extracellular domain that binds CD79b, or CD79b and CD 19. Further, this invention is related to methods of treating cancer, plasma cell diseases or disorders, or autoimmune diseases or disorders.

Originalsprog	Engelsk
IPC	C07K 16/ 32 A I
Patentnummer	WO2018226958
Land/Område	Danmark
Prioritetsdato	07/02/2018
Prioritetsnummer	US201862627514P
Status	Udgivet - 13. dec. 2018

Citationsformater

@misc{1e62d4d29adf464aae5faa02ab7773e3,

title = "T cells expressing a chimeric antigen receptor",

abstract = "Described herein are methods for producing and utilizing T cells comprising chimeric antigen receptors (CAR) comprising an extracellular domain that binds CD79b, or CD79b and CD 19. Further, this invention is related to methods of treating cancer, plasma cell diseases or disorders, or autoimmune diseases or disorders.",

author = "Marcela Maus and Maria Ormh{\o}j and Torben Barington",

year = "2018",

month = dec,

day = "13",

language = "English",

type = "Patent",

note = "WO2018226958; C07K 16/ 32 A I",

}

TY - PAT

T1 - T cells expressing a chimeric antigen receptor

AU - Maus, Marcela

AU - Ormhøj, Maria

AU - Barington, Torben

PY - 2018/12/13

Y1 - 2018/12/13

N2 - Described herein are methods for producing and utilizing T cells comprising chimeric antigen receptors (CAR) comprising an extracellular domain that binds CD79b, or CD79b and CD 19. Further, this invention is related to methods of treating cancer, plasma cell diseases or disorders, or autoimmune diseases or disorders.

AB - Described herein are methods for producing and utilizing T cells comprising chimeric antigen receptors (CAR) comprising an extracellular domain that binds CD79b, or CD79b and CD 19. Further, this invention is related to methods of treating cancer, plasma cell diseases or disorders, or autoimmune diseases or disorders.

M3 - Patent

M1 - WO2018226958

ER -

T cells expressing a chimeric antigen receptor

Abstrakt

Fingeraftryk

Citationsformater